Long-term Evaluation of the Linox Family ICD Leads Registry (GALAXY)
GALAXY
GALAXY Registry: Long-term Evaluation of the Linox Family ICD Leads Registry
GALAXY
GALAXY Registry: Long-term Evaluation of the Linox Family ICD Leads Registry
Sponsor study identifier
observational
1,997
1 country
85
Study Start
December 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2016
Actual (reported)Study Completion
December 2016
Actual (reported)The objective of this study is to confirm the long-term safety and reliability of the Linox Lead System as used with BIOTRONIK ICDs. The GALAXY registry will provide data to fully characterize ICD lead failures, from implant through 5 years, including those failures contributing to patients losing pacing or defibrillation therapy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2016
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2008
Date type not reportedThis date has not been verified as actual or estimated.
February 2, 2009
Actual (reported)February 4, 2009
Actual (reported)December 2016
Actual (reported)December 2016
Actual (reported)February 15, 2019
Actual (reported)Percentage of Subjects Who Are Free of Complications Related to the Linox ICD Lead
The overall incidence of complications (serious adverse events that require additional invasive intervention to resolve or specific non-invasive actions) related to the Linox ICD leads implanted with a market-released BIOTRONIK ICD device was evaluated. This was evaluated as a serious adverse event free-rate (SAEFR).
5 years
Number of Subjects Who Experienced Primary Outcome 1 Complication(s) Per Individual Complication Type
Evaluation of the individual types of serious adverse events (SAEs) contributing to primary outcome 1 and their associated SAE category.
5 years
Number of Subjects Who Experienced Serious Adverse Event(s) Excluded From Primary Outcome 1 (ICD, Device, and Implant Procedure Related) Through 5 Years Post-Implant.
5 years
Number of Subjects Who Experienced Serious Adverse Event(s) Excluded From Primary Outcome 1 (RA Lead Related) Through 5 Years Post-Implant.
5 years
Pacing Threshold Measurements for the Linox Lead System at Scheduled GALAXY Registry Follow-ups Through 5 Years Post-implant.
5 years
Sensing Measurements for the Linox Lead System at Scheduled GALAXY Registry Follow-ups Through 5 Years Post-implant.
5 years
Pacing Impedance Measurements for the Linox Lead System at Scheduled GALAXY Registry Follow-ups Through 5 Years Post-implant.
5 years
Collecting long-term safety and efficacy data on a family of market-released ICD leads.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients will be obtained from the investigators' general patient population according to the inclusion and exclusion criteria described below.
Albertville, Alabama, United States
Birmingham, Alabama, United States
Gadsden, Alabama, United States
Jasper, Alabama, United States
Glendale, Arizona, United States
Mesa, Arizona, United States
Phoenix, Arizona, United States
Good ED, Cakulev I, Orlov MV, Hirsh D, Simeles J, Mohr K, Moll P, Bloom H. Long-Term Evaluation of Biotronik Linox and Linox(smart) Implantable Cardioverter Defibrillator Leads. J Cardiovasc Electrophysiol. 2016 Jun;27(6):735-42. doi: 10.1111/jce.12971. Epub 2016 May 3.
1,997 participants (actual enrollment reported by the registry).
First Submitted
February 2, 2009
First Posted
February 4, 2009
Study Start
December 2008
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Scottsdale, Arizona, United States
Tucson, Arizona, United States
Burbank, California, United States
Fairfield, California, United States
Fountain Valley, California, United States
Glendale, California, United States
Hawthorne, California, United States
Inglewood, California, United States
Los Angeles, California, United States
Mission Viejo, California, United States
Northridge, California, United States
Rancho Mirage, California, United States
Santa Barbara, California, United States
Santa Maria, California, United States
Torrance, California, United States
Aurora, Colorado, United States
Boulder, Colorado, United States
Brooksville, Florida, United States
Daytona Beach, Florida, United States
Inverness, Florida, United States
Jacksonville, Florida, United States
Melbourne, Florida, United States
Miami, Florida, United States
Naples, Florida, United States
New Smyrna Beach, Florida, United States
Pensacola, Florida, United States
Port Charlotte, Florida, United States
Atlanta, Georgia, United States
Alton, Illinois, United States
Centralia, Illinois, United States
Chicago, Illinois, United States
Hammond, Indiana, United States
Jeffersonville, Indiana, United States
Owensboro, Kentucky, United States
Lafayette, Louisiana, United States
Lake Charles, Louisiana, United States
Marrero, Louisiana, United States
Baltimore, Maryland, United States
Cumberland, Maryland, United States
Rockville, Maryland, United States
Salisbury, Maryland, United States
Grand Rapids, Michigan, United States
Ypsilanti, Michigan, United States
Biloxi, Mississippi, United States
Bridgeton, Missouri, United States
Crystal City, Missouri, United States
St Louis, Missouri, United States
Haddon Heights, New Jersey, United States
Rochester, New York, United States
Charlotte, North Carolina, United States
Concord, North Carolina, United States
Gastonia, North Carolina, United States
Greensboro, North Carolina, United States
Grand Forks, North Dakota, United States
Columbus, Ohio, United States
Massillon, Ohio, United States
Toledo, Ohio, United States
Zanesville, Ohio, United States
Salem, Oregon, United States
Tualatin, Oregon, United States
Chinchilla, Pennsylvania, United States
Phoenixville, Pennsylvania, United States
Yardley, Pennsylvania, United States
Columbia, South Carolina, United States
Florence, South Carolina, United States
Greenville, South Carolina, United States
Greenwood, South Carolina, United States
Lancaster, South Carolina, United States
Rock Hill, South Carolina, United States
Chattanooga, Tennessee, United States
Amarillo, Texas, United States
El Paso, Texas, United States
Fort Worth, Texas, United States
Houston, Texas, United States
Kingwood, Texas, United States
McAllen, Texas, United States
McKinney, Texas, United States
Yakima, Washington, United States
Primary Completion
December 2016
Actual (reported)Study Completion
December 2016
Actual (reported)Last Updated
February 15, 2019
Results First Posted
February 15, 2019
Record last verified: 2018-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: